Leucine Rich Repeat (In FLII) Interacting Protein 1 (LRRFIP1) (Middle Region) Peptide
Quick Overview for Leucine Rich Repeat (In FLII) Interacting Protein 1 (LRRFIP1) (Middle Region) Peptide (ABIN8104232)
Target
Origin
Source
Application
-
-
Protein Region
- Middle Region
-
Purpose
- LRRFIP1 Peptide - middle region
-
Sequence
- ERQKEFFDSV RSERDDLREE VVMLKEELKK HGIILNSEIA TNGETSDTLN
-
-
-
-
Application Notes
- Optimal working dilution should be determined by the investigator.
-
Comment
-
This is a synthetic peptide designed for use in combination with anti-LRRFIP1 Antibody (ARP59016_P050),. It may block above mentioned antibody from binding to its target protein in western blot and/or immunohistochecmistry under proper experimental settings. There is no guarantee for its use in other applications. Please inquire for more details.
-
Restrictions
- For Research Use only
-
-
-
Format
- Lyophilized
-
Reconstitution
- Add 100 µL of sterile PBS. Final peptide concentration is 1 mg/mL in PBS.
-
Buffer
- Lyophilized powder
-
Storage
- -20 °C
-
Storage Comment
- For longer periods of storage, store at -20 °C. Avoid repeat freeze-thaw cycles.
-
-
- LRRFIP1 (Leucine Rich Repeat (In FLII) Interacting Protein 1 (LRRFIP1))
-
Background
-
Background Information: LRRFIP1 is a transcriptional repressor which preferentially binds to the GC-rich consensus sequence (5'-AGCCCCCGGCG-3') and may regulate expression of TNF, EGFR and PDGFA. LRRFIP1 may control smooth muscle cells proliferation following artery injury through PDGFA repression. LRRFIP1 may also bind double-stranded RNA.
Alternative Symbols: FLAP-1, FLAP1, FLIIAP1, GCF-2, GCF2, HUFI-1, TRIP
-
Molecular Weight
- 73kDa
-
Gene ID
- 9208
-
NCBI Accession
- NP_001131022
-
UniProt
- E9PGZ2
Target
-
